€21.88 Pfizer (PFE.DE XETRA) 29 Jan 2026 ahead of earnings: guidance will set next move
PFE.DE stock trades at €21.88 intraday on 29 Jan 2026 as investors await Feb 3 earnings and guidance
PFE.DE stock trades at €21.88 intraday on 29 Jan 2026 as investors await Feb 3 earnings and guidance
Roche stock in focus: 2025 profit +50% to CHF 13.8bn, sales CHF 61.5bn, dividend proposed at CHF 9.80, and a steady 2026 outlook. What it means for Swiss investors.
201000-share volume spike puts BLR.CN stock in focus during market hours; high relative volume and overbought RSI signal active trading
Pre-market update on 1TT.AX stock: down 33% to A$0.001 with heavy volume and liquidity risks
Hindustan Zinc OFS opens for retail today at a ₹685 floor. Track Hindustan Zinc share price, Vedanta stake sale size, pricing cues, and key watchpoints for Indian investors.
FECHF stock at $3.49 on 29 Jan 2026; Meyka AI projects $5.51 12-month target for FECHF stock
TECHCON.BO stock closed 29 Jan 2026 at INR 99.54. Oversold bounce setup, Meyka AI forecast and targets for short-term traders.
Intraday: ALEUP.PA stock falls 15.13% to €0.0763 on 29 Jan 2026; volume spike and weak fundamentals signal caution
Microsoft earnings: Azure growth slightly beats but guidance stays near 37–38% as AI capex stays high. OpenAI exposure near 45% of cloud backlog raises risk. What it means for Singapore investors.
3738.T stock: pre-market volume spike to 157,000 shares at JPY 2,659. Quick fundamentals, Meyka AI grade and a JPY 3,300 forecast